Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Medicarpin

🥰Excellent
Catalog No. TN1918Cas No. 32383-76-9

N-Methylnicotinamide is one of the endogenous metabolites that ameliorates endothelial dysfunction.

Medicarpin

Medicarpin

🥰Excellent
Purity: 100%
Catalog No. TN1918Cas No. 32383-76-9
N-Methylnicotinamide is one of the endogenous metabolites that ameliorates endothelial dysfunction.
Pack SizePriceAvailabilityQuantity
1 mg$159In Stock
5 mg$396In Stock
10 mg$530In Stock
25 mg$859In Stock
50 mg$1,180In Stock
100 mg$1,590In Stock
1 mL x 10 mM (in DMSO)$341In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Medicarpin"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
N-Methylnicotinamide is one of the endogenous metabolites that ameliorates endothelial dysfunction.
In vitro
To this aim, 7- and 30-day-old plants were treated with 0, 120, 240, 500, and 1,000 μM Pb during 10 days. The content of Medicarpin was determined by HPLC, and the extent of Medicarpin production was deduced from the result of semiquantitative RT-PCR performed on PAL, CHS, and VR genes. HPLC results indicated that Medicarpin concentration has been reduced in the roots, while its exudation to the culture medium has been increased. RT-PCR results indicated that the transcript levels of PAL, CHS, and VR genes have not been affected following Pb stress in seedlings. At the vegetative stage, transcript levels of PAL and CHS genes have been reduced in the roots. However, the transcript level of VR gene increased at 120 and 240 μM Pb, while it decreased at higher concentrations. In the shoot, the transcript levels of PAL, CHS, and VR genes were increased following increased concentration of lead in the medium[1]
Chemical Properties
Molecular Weight270.28
FormulaC16H14O4
Cas No.32383-76-9
Smiles[H][C@@]12COc3cc(O)ccc3[C@]1([H])Oc1cc(OC)ccc21
Relative Density.1.319g/cm3
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 22.5 mg/mL (83.25 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.6999 mL18.4993 mL36.9987 mL184.9933 mL
5 mM0.7400 mL3.6999 mL7.3997 mL36.9987 mL
10 mM0.3700 mL1.8499 mL3.6999 mL18.4993 mL
20 mM0.1850 mL0.9250 mL1.8499 mL9.2497 mL
50 mM0.0740 mL0.3700 mL0.7400 mL3.6999 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Medicarpin | purchase Medicarpin | Medicarpin cost | order Medicarpin | Medicarpin chemical structure | Medicarpin in vitro | Medicarpin formula | Medicarpin molecular weight